130 related articles for article (PubMed ID: 3615193)
21. Mixed myelodysplastic syndrome and myeloproliferative disorder with bone marrow and pulmonary fibrosis: the role of megakaryocytes.
Rosenstingl S; Brouland JP; Zini JM; Tobelem G; Dupuy E
Acta Haematol; 2003; 109(3):145-9. PubMed ID: 12714825
[TBL] [Abstract][Full Text] [Related]
22. Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules.
Gerrard JM; Phillips DR; Rao GH; Plow EF; Walz DA; Ross R; Harker LA; White JG
J Clin Invest; 1980 Jul; 66(1):102-9. PubMed ID: 6156948
[TBL] [Abstract][Full Text] [Related]
23. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
[TBL] [Abstract][Full Text] [Related]
24. Immunological localisation of beta-thromboglobulin and platelet factor 4 in human megakaryocytes and platelets.
McLaren KM; Pepper DS
J Clin Pathol; 1982 Nov; 35(11):1227-31. PubMed ID: 6183294
[TBL] [Abstract][Full Text] [Related]
25. Ultrastructure of bone marrow tissue in so-called primary (idiopathic) myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia). I. Abnormalities of megakaryopoiesis and thrombocytes.
Thiele J; Kuemmel T; Sander C; Fischer R
J Submicrosc Cytol Pathol; 1991 Jan; 23(1):93-107. PubMed ID: 2036630
[TBL] [Abstract][Full Text] [Related]
26. Thrombopoietin-responsive essential thrombocythaemia with myelofibrosis.
Ozaki S; Kosaka M; Ozaki K; Wakatsuki S; Hashimoto T; Miyazaki H
Br J Haematol; 1997 May; 97(2):449-52. PubMed ID: 9163612
[TBL] [Abstract][Full Text] [Related]
27. Aberrant expression of platelet-derived growth factor (PDGF) and PDGF receptor-alpha is associated with advanced bone marrow fibrosis in idiopathic myelofibrosis.
Bock O; Loch G; Büsche G; von Wasielewski R; Schlué J; Kreipe H
Haematologica; 2005 Jan; 90(1):133-4. PubMed ID: 15642683
[TBL] [Abstract][Full Text] [Related]
28. Myelofibrosis: a role for platelet derived growth factor (PDGF)?
Romano M; Poggi A
Haematologica; 1986; 71(5):359-61. PubMed ID: 3096830
[No Abstract] [Full Text] [Related]
29. Disruption of microtubules in vivo by vincristine induces large membrane complexes and other cytoplasmic abnormalities in megakaryocytes and platelets of normal rats like those in human and Wistar Furth rat hereditary macrothrombocytopenias.
Stenberg PE; McDonald TP; Jackson CW
J Cell Physiol; 1995 Jan; 162(1):86-102. PubMed ID: 7814453
[TBL] [Abstract][Full Text] [Related]
30. Golgi complexes in hypogranular platelet syndromes.
White JG
Platelets; 2005 Feb; 16(1):51-60. PubMed ID: 15763897
[TBL] [Abstract][Full Text] [Related]
31. Origin of platelet-derived growth factor in megakaryocytes in guinea pigs.
Chernoff A; Levine RF; Goodman DS
J Clin Invest; 1980 Apr; 65(4):926-30. PubMed ID: 7358851
[TBL] [Abstract][Full Text] [Related]
32. Platelet-derived growth factor enhances ex vivo expansion of megakaryocytic progenitors from human cord blood.
Su RJ; Li K; Yang M; Zhang XB; Tsang KS; Fok TF; Li CK; Yuen PM
Bone Marrow Transplant; 2001 May; 27(10):1075-80. PubMed ID: 11438824
[TBL] [Abstract][Full Text] [Related]
33. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
[TBL] [Abstract][Full Text] [Related]
34. [Histology of bone marrow in Vaquez's disease and the problem of myelosclerosis. 70 biopsies].
Duhamel G; Najman A; André R
Nouv Rev Fr Hematol; 1970; 10(2):209-22. PubMed ID: 4246273
[No Abstract] [Full Text] [Related]
35. Spontaneous in vitro megakaryocyte colony formation in primary thrombocythemia: relation to platelet factor 4 plasma level and beta-thromboglobulin/platelet factor 4 ratio.
Abgrall JF; Berthou C; Cauvin JM; Autrand C; Renard I; Le Niger C; Guern G; Blouch MT; Sensebé L; Brière J
Acta Haematol; 1992; 87(3):118-21. PubMed ID: 1386487
[TBL] [Abstract][Full Text] [Related]
36. Medich giant platelet disorder: a unique alpha granule deficiency I. Structural abnormalities.
White JG
Platelets; 2004 Sep; 15(6):345-53. PubMed ID: 15370096
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiological mechanisms operating in the development of myelofibrosis: role of megakaryocytes.
Castro-Malaspina H; Moore MA
Nouv Rev Fr Hematol (1978); 1982; 24(4):221-6. PubMed ID: 6292827
[TBL] [Abstract][Full Text] [Related]
38. [Congenital deficiency of platelet alpha-granules and medullary reticulinic fibrosis. Physiopathogenic hypothesis (author's transl)].
Drouet L; Praloran V; Cywiner-Golenzer C; Trehen C; Flandrin G; Caen JP
Nouv Rev Fr Hematol (1978); 1981; 23(2):95-100. PubMed ID: 6974857
[TBL] [Abstract][Full Text] [Related]
39. Gray platelet syndrome. Demonstration of alpha granule membranes that can fuse with the cell surface.
Rosa JP; George JN; Bainton DF; Nurden AT; Caen JP; McEver RP
J Clin Invest; 1987 Oct; 80(4):1138-46. PubMed ID: 2443536
[TBL] [Abstract][Full Text] [Related]
40. A new genetic isolate of gray platelet syndrome (GPS): clinical, cellular, and hematologic characteristics.
Falik-Zaccai TC; Anikster Y; Rivera CE; Horne MK; Schliamser L; Phornphutkul C; Attias D; Hyman T; White JG; Gahl WA
Mol Genet Metab; 2001 Nov; 74(3):303-13. PubMed ID: 11708859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
